KR100784169B1 - 만성변비의 개선 기능을 갖는 건강기능식품 - Google Patents
만성변비의 개선 기능을 갖는 건강기능식품 Download PDFInfo
- Publication number
- KR100784169B1 KR100784169B1 KR1020050108050A KR20050108050A KR100784169B1 KR 100784169 B1 KR100784169 B1 KR 100784169B1 KR 1020050108050 A KR1020050108050 A KR 1020050108050A KR 20050108050 A KR20050108050 A KR 20050108050A KR 100784169 B1 KR100784169 B1 KR 100784169B1
- Authority
- KR
- South Korea
- Prior art keywords
- constipation
- extract
- red ginseng
- functional food
- administration
- Prior art date
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 97
- 235000013376 functional food Nutrition 0.000 title claims abstract description 24
- 230000006872 improvement Effects 0.000 title abstract description 17
- 235000001497 healthy food Nutrition 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 56
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 49
- 230000001684 chronic effect Effects 0.000 claims abstract description 40
- 230000036541 health Effects 0.000 claims abstract description 24
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 20
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 20
- 241000287828 Gallus gallus Species 0.000 claims abstract description 20
- 240000002045 Guettarda speciosa Species 0.000 claims abstract description 17
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 17
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 7
- 229940069445 licorice extract Drugs 0.000 claims abstract description 7
- 239000010865 sewage Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 8
- 235000015872 dietary supplement Nutrition 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 235000019206 astragalus extract Nutrition 0.000 claims 1
- 239000000469 ethanolic extract Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000012669 liquid formulation Substances 0.000 claims 1
- 235000006533 astragalus Nutrition 0.000 abstract description 16
- 241001061264 Astragalus Species 0.000 abstract description 15
- 210000004233 talus Anatomy 0.000 abstract description 15
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract description 12
- 229940010454 licorice Drugs 0.000 abstract description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 description 28
- 230000000052 comparative effect Effects 0.000 description 25
- 230000000694 effects Effects 0.000 description 19
- 230000006870 function Effects 0.000 description 18
- 238000012360 testing method Methods 0.000 description 14
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 12
- 241001247821 Ziziphus Species 0.000 description 12
- 235000020710 ginseng extract Nutrition 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 240000004371 Panax ginseng Species 0.000 description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 description 10
- 235000008434 ginseng Nutrition 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 240000004670 Glycyrrhiza echinata Species 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 150000002482 oligosaccharides Chemical class 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 5
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000512259 Ascophyllum nodosum Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010073508 Drug reaction with eosinophilia and systemic symptoms Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 240000006079 Schisandra chinensis Species 0.000 description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000003871 intestinal function Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 235000013856 polydextrose Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical group 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241001454694 Clupeiformes Species 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000331432 Cynanchum wilfordii Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 235000019513 anchovy Nutrition 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000002973 irritant agent Substances 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 229910001388 sodium aluminate Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pediatric Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
실험군 | 이동 증가율(%) |
대조군 | 100.0 |
실시예 1 | 139.5 |
실시예 2 | 167.3 |
비교예 1 | 125.2 |
평가 등급 | 평가 지표 |
현저한 효과 | 변비가 거의 완전히 소실된 경우 |
유효 | 경미한 변비가 계속되거나 현저하게 개선된 경우 |
약간 유효 | 변비의 개선이 있으나 불충분한 경우 |
무효 | 변화가 없는 경우 |
평가등급 | 판정 수 | 비 고 | |
실시예 1 | 현저한 효과 | 4 | 63.3% 만성변비 개선 효과 |
유효 | 15 | ||
약간 유효 | 8 | ||
무효 | 3 | ||
계 | 30 | ||
실시예 2 | 현저한 효과 | 20 | 86.7% 만성변비 개선 효과 |
유효 | 6 | ||
약간 유효 | 3 | ||
무효 | 1 | ||
계 | 30 | ||
비교예 1 | 현저한 효과 | 1 | 26.7% 만성변비 개선 효과 |
유효 | 7 | ||
약간 유효 | 19 | ||
무효 | 3 | ||
계 | 30 |
6회 이상 | 3 내지 5회 | 2회 이하 | 비 고 | ||
실시예 1 | 투여전 | 5 | 25 | ||
투여후 | 4 | 15 | 11 | ||
실시예 2 | 투여전 | 4 | 26 | ||
투여후 | 20 | 6 | 4 | ||
비교예 1 | 투여전 | 3 | 27 | ||
투여후 | 1 | 7 | 22 |
고형변 | 덩어리변 | 반고형변 | 연변 | 비 고 | ||
실시예 1 | 투여전 | 25 | 4 | 1 | ||
투여후 | 3 | 6 | 15 | 4 | ||
실시예 2 | 투여전 | 26 | 2 | 2 | ||
투여후 | 1 | 3 | 6 | 20 | ||
비교예 1 | 투여전 | 27 | 1 | 2 | ||
투여후 | 3 | 19 | 7 | 1 |
주간 평균 힘주기 빈도 | 비 고 | ||||
항상 | 3회 내지 6회 | 2회 이하 | |||
실시예 1 | 투여전 | 30 | |||
투여후 | 9 | 7 | 14 | ||
실시예 2 | 투여전 | 30 | |||
투여후 | 1 | 6 | 23 | ||
비교예 1 | 투여전 | 30 | |||
투여후 | 16 | 7 | 7 |
주간 평균 폐쇄감의 빈도 | 비 고 | ||||
항상 | 3회 내지 6회 | 2회 이하 | |||
실시예 1 | 투여전 | 30 | |||
투여후 | 9 | 10 | 11 | ||
실시예 2 | 투여전 | 30 | |||
투여후 | 4 | 8 | 18 | ||
비교예 1 | 투여전 | 30 | |||
투여후 | 17 | 7 | 6 |
잔변감 있음 | 잔변감 없음 | 비 고 | ||
실시예 1 | 투여전 | 30 | ||
투여후 | 19 | 11 | ||
실시예 2 | 투여전 | 30 | ||
투여후 | 12 | 18 | ||
비교예 1 | 투여전 | 30 | ||
투여후 | 21 | 9 |
Claims (7)
- 홍삼 추출물 5~15중량%, 당귀 추출물 10~44.9중량%, 백하수오 추출물 10~15중량%, 홍화씨 추출물 10~15중량%, 육계 추출물 10~15중량%, 황기 추출물 10~15중량%, 대추 추출물 10~15중량% 및 감초 추출물 0.1~0.5중량%를 함유하며, 상기 추출물은 열수 또는 에탄올 추출물인 것을 특징으로 하는 만성변비 개선용 건강기능식품 조성물.
- 제 1 항에 따른 생약 조성물을 함유하는, 만성변비 개선용 건강기능식품용 액상 제제.
- 제 2 항에 있어서, 파우치, 치어팩 또는 병 형태의 음료형태인 건강기능식품용 액상 제제.
- 제 1 항에 따른 생약 조성물을 함유하는, 만성변비 개선용 건강기능식품용 고형 제제.
- 제 4 항에 있어서, 제형이 캡슐제, 환제 또는 정제임을 특징으로 하는 변비 개선용 건강기능식품용 고형 제제.
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050108050A KR100784169B1 (ko) | 2005-11-11 | 2005-11-11 | 만성변비의 개선 기능을 갖는 건강기능식품 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050108050A KR100784169B1 (ko) | 2005-11-11 | 2005-11-11 | 만성변비의 개선 기능을 갖는 건강기능식품 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070050624A KR20070050624A (ko) | 2007-05-16 |
KR100784169B1 true KR100784169B1 (ko) | 2007-12-10 |
Family
ID=38274098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050108050A KR100784169B1 (ko) | 2005-11-11 | 2005-11-11 | 만성변비의 개선 기능을 갖는 건강기능식품 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100784169B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101034809B1 (ko) * | 2011-03-03 | 2011-05-16 | 남영제약영농조합법인 | 사포닌 함량이 증진된 홍삼 추출물의 제조방법 및 상기 방법으로 제조된 홍삼 추출물 |
CN103083504A (zh) * | 2013-03-07 | 2013-05-08 | 于晓红 | 一种治疗便秘的中药组合物 |
KR101866915B1 (ko) * | 2018-04-12 | 2018-06-12 | 조형권 | 변비 개선용 한방 생약재 농축 과립의 제조방법 및 이에 의해 제조된 농축 과립 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980071887A (ko) * | 1998-05-18 | 1998-10-26 | 이지은 | 건강증진용 차 |
KR20020012436A (ko) * | 2000-08-07 | 2002-02-16 | 한완석 | 변비 예방 및 치료용 건강식품 조성물 |
KR20020024020A (ko) * | 2002-01-08 | 2002-03-29 | 추영진 | 홍화씨를 주성분으로 한 건강식품의 제조방법 및 건강식품 |
KR20020063734A (ko) * | 2001-01-30 | 2002-08-05 | 주식회사 한국의과학연구소 | 자양 강장을 위한 약물 추출방법 |
KR20040063430A (ko) * | 2003-01-07 | 2004-07-14 | 한화수 | 변비 개선용 천연 조성물 및 이의 제조방법 |
-
2005
- 2005-11-11 KR KR1020050108050A patent/KR100784169B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19980071887A (ko) * | 1998-05-18 | 1998-10-26 | 이지은 | 건강증진용 차 |
KR20020012436A (ko) * | 2000-08-07 | 2002-02-16 | 한완석 | 변비 예방 및 치료용 건강식품 조성물 |
KR20020063734A (ko) * | 2001-01-30 | 2002-08-05 | 주식회사 한국의과학연구소 | 자양 강장을 위한 약물 추출방법 |
KR20020024020A (ko) * | 2002-01-08 | 2002-03-29 | 추영진 | 홍화씨를 주성분으로 한 건강식품의 제조방법 및 건강식품 |
KR20040063430A (ko) * | 2003-01-07 | 2004-07-14 | 한화수 | 변비 개선용 천연 조성물 및 이의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20070050624A (ko) | 2007-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101346244B1 (ko) | 생약 제제를 포함하는 숙취 예방 또는 해소용 조성물 | |
KR20030059984A (ko) | 인삼의 가공방법 및 가공인삼 추출물의 용도 | |
JP5275251B2 (ja) | 肝臓疾患を予防及び処置するための組合せ薬草の抽出物を含む組成物 | |
CN101327013A (zh) | 养胃护肠米粉及其配制方法 | |
KR100947278B1 (ko) | 하엽 추출물을 주성분으로 하는 탄수화물 및 지방 흡수억제 활성을 가지는 생약 조성물과 이의 제조 방법 | |
CN112006137A (zh) | 一种健脾养胃苏菔茶及其制备方法 | |
KR100597235B1 (ko) | 오미자 추출물을 유효성분으로 함유하는 관절염 예방 및치료용 조성물 | |
KR20070101441A (ko) | 혼합 생약 추출물을 유효성분으로 함유하는 간 기능 개선용조성물 | |
CN104208224B (zh) | 一种肉鸡用复方中药组合物及其制备方法和应用 | |
KR100784169B1 (ko) | 만성변비의 개선 기능을 갖는 건강기능식품 | |
KR20130009901A (ko) | 혈행개선 및 기력보강과 골다공증 예방을 위한 건강식품 조성물 | |
KR20050114929A (ko) | 변비의 치료 및 예방용 조성물 | |
KR100815277B1 (ko) | 홍삼 산성다당체 및 구기자추출물을 함유하는 항고지혈증제 | |
KR102014922B1 (ko) | 감초 유래 글라블리딘을 유효성분으로 하는 소화기능 개선용 조성물 | |
KR101479096B1 (ko) | 생약혼합물의 추출물을 함유하는 산전산후부종 예방 또는 개선용 건강기능식품 | |
KR102045847B1 (ko) | 관능성 및 항당뇨 활성이 증대된 옥미수·호박 가미 경옥고 | |
KR101668447B1 (ko) | 숙취 해소용 조성물 및 이를 포함하는 건강기능 식품 | |
KR20200061446A (ko) | 함초를 이용한 식품 조성물 및 그 제조방법 | |
CN1927298A (zh) | 一种治疗胃部及肠道疾病的中药制剂及其制备方法 | |
KR20210041387A (ko) | 갈화 추출물 및 차전자피 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
KR20020074905A (ko) | 무 추출물을 함유하는 한방 건강보조식품 조성물 | |
CN1262297C (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN108904694A (zh) | 一种用于提高免疫的牡蛎山药颗粒及其制备方法 | |
KR100538983B1 (ko) | 생약추출물이 함유된 간기능 개선용 약학 조성물 | |
KR20170103602A (ko) | 진피를 포함한 생약 조합 추출물을 유효성분으로 함유하는 변비 예방 및 치료용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
FPAY | Annual fee payment |
Payment date: 20121127 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131125 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141121 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151130 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161130 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171128 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20191114 Year of fee payment: 13 |